Fingerprint
Dive into the research topics of 'Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Taxane chemotherapy vs antiandrogen agents as first-line therapy for metastatic castration-resistant prostate cancer
Guru Sonpavde, Ahong Huang, Li Wang, Onur Baser, Raymond Miao
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations